ESG is becoming a critical priority for the medtech industry in the Asia‑Pacific region as customer expectations and market dynamics shift. Nearly 70 percent of surveyed customers expect environmental, social, and governance factors to become a core purchasing criterion, signaling that ESG is no longer optional. As the region enters a new era of rapid medical innovation, companies are under pressure to integrate sustainability, ethical governance, and social responsibility into strategy and operations. Advances in digital health and telemedicine will increasingly be paired with environmental and social considerations, making ESG a key driver of trust, competitiveness, and long‑term growth for medtech players in Asia‑Pacific.

Join for free to read